FFA
VIR icon

Farther Finance Advisors’s Vir Biotechnology VIR Stock Holding History

Farther Finance Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.5K Buy
638
+71
+13% +$675 ﹤0.01% 4653
2026
Q1 		$5.11K Buy
567
+514
+970% +$4.1K ﹤0.01% 4481
2025
Q4 		$320 Buy
53
+4
+8% +$24 ﹤0.01% 5122
2025
Q3 		$280 Sell
49
-135
-73% -$690 ﹤0.01% 4654
2025
Q2 		$927 Buy
+184
New +$987 ﹤0.01% 3921
2024
Q4 		– Sell
-485
Closed -$3.63K – 4158
2024
Q3 		$3.63K Buy
485
+60
+14% +$521 ﹤0.01% 2776
2024
Q2 		$3.87K Sell
425
-31
-7% -$297 ﹤0.01% 2508
2024
Q1 		$4.65K Buy
456
+26
+6% +$265 ﹤0.01% 2101
2023
Q4 		$4.33K Sell
430
-11
-2% -$101 ﹤0.01% 2042
2023
Q3 		$4.13K Buy
+441
New +$6.29K ﹤0.01% 1580

Other funds holding VIR

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FG
Foster Group West Des Moines, Iowa $3.76B AUM 21.29% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Farther Finance Advisors's VIR Position: Q2 2026 in Review

Farther Finance Advisors increased its Vir Biotechnology (VIR) stake by 13% in Q2 2026, buying an estimated $675 and bringing the position to 638 shares worth $6.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4653.

Farther Finance Advisors first reported a position in VIR in Q3 2023 and has held it in 10 quarters since. 14 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Farther Finance Advisors held 638 shares of Vir Biotechnology worth $6.5K as of Q2 2026.
  • Farther Finance Advisors bought 71 Vir Biotechnology shares in Q2 2026, an estimated $675.
  • Vir Biotechnology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4653 holding.
  • Farther Finance Advisors first reported a position in Vir Biotechnology in Q3 2023 and has held it in 10 quarters since.
  • 14 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.